AbbVie
ABBV
1,605 hedge funds and large institutions have $61.7B invested in AbbVie in 2015 Q3 according to their latest regulatory filings, with 77 funds opening new positions, 623 increasing their positions, 680 reducing their positions, and 110 closing their positions.
32% more call options, than puts
Call options by funds: $1.2B | Put options by funds: $907M
8% less repeat investments, than reductions
Existing positions increased: 623 | Existing positions reduced: 680
3% less funds holding
Funds holding: 1,653 → 1,605 (-48)
6.53% less ownership
Funds ownership: 75.37% → 68.84% (-6.5%)
23% less capital invested
Capital invested by funds: $80.2B → $61.7B (-$18.5B)
30% less first-time investments, than exits
New positions opened: 77 | Existing positions closed: 110
38% less funds holding in top 10
Funds holding in top 10: 142 → 88 (-54)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$549M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$544M |
| 3 |
WIM
Woodford Investment Management
London,
United Kingdom
|
+$344M |
| 4 |
HCM
Highfields Capital Management
Boston,
Massachusetts
|
+$216M |
| 5 |
Two Sigma Investments
New York
|
+$196M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.44B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$715M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$523M |
| 4 |
PC
PointState Capital
New York
|
-$294M |
| 5 |
State Street
Boston,
Massachusetts
|
-$249M |
ABBV Hedge Fund Activity: Q3 2015 in Review
1,605 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q3 2015, worth a combined $61.7B — down 23% from $80.2B a quarter earlier.
Sellers outnumbered buyers: 110 funds closed out of ABBV and 77 opened new positions — a net loss of 33 holders — while 680 trimmed existing stakes and 623 added.
The largest buyer was Bank of America, adding an estimated $549M. The largest seller was Morgan Stanley, cutting an estimated $1.44B.
- 1,605 institutional investors held AbbVie (ABBV) as of Q3 2015, down from 1,653 in Q2 2015.
- Funds reported $61.7B of AbbVie stock for Q3 2015, down 23% quarter-over-quarter.
- 77 funds opened new AbbVie positions in Q3 2015 and 110 closed out, a net change of -33 holders.
- The largest AbbVie buyer in Q3 2015 was Bank of America, an estimated $549M added.
- The largest AbbVie seller in Q3 2015 was Morgan Stanley, an estimated $1.44B sold.
Based on aggregated 13F filings for Q3 2015.